Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-05-16 4:08 pm Purchase | 2022-05-06 | 13G | Arvinas, Inc. ARVN | EcoR1 Capital, LLC | 3,123,300 5.900% | 3,123,300 (New Position) | Filing History |
| 2022-04-26 12:58 pm Purchase | 2022-04-21 | 13G | Voyager Therapeutics, Inc. VYGR | EcoR1 Capital, LLC | 4,276,507 11.100% | 719,000 (+20.21%) | Filing History |
| 2022-04-11 4:26 pm Purchase | 2022-03-31 | 13G | Reata Pharmaceuticals, Inc. RETA | EcoR1 Capital, LLC | 1,975,611 6.300% | 1,975,611 (New Position) | Filing History |
| 2022-04-07 6:23 pm Purchase | 2022-03-02 | 13G | HOOKIPA Pharma Inc. HOOK | EcoR1 Capital, LLC | 509,086 9.990% | 509,086 (New Position) | Filing History |
| 2022-03-14 3:55 pm Purchase | 2022-03-11 | 13G | Surface Oncology, Inc. SURF | EcoR1 Capital, LLC | 4,653,000 9.900% | 4,604,442 (+9482.36%) | Filing History |
| 2022-02-14 4:55 pm Purchase | 2022-02-04 | 13G | Aligos Therapeutics, Inc. ALGS | EcoR1 Capital, LLC | 128,532 7.500% | 128,532 (New Position) | Filing History |
| 2022-02-14 4:02 pm Purchase | 2021-12-31 | 13G | Arcus Biosciences, Inc. RCUS | EcoR1 Capital, LLC | 5,523,358 7.900% | 951,311 (+20.81%) | Filing History |
| 2022-02-14 4:01 pm Unchanged | 2021-12-31 | 13G | Voyager Therapeutics, Inc. VYGR | EcoR1 Capital, LLC | 3,557,507 9.400% | 0 (Unchanged) | Filing History |
| 2022-02-14 3:58 pm Purchase | 2021-12-31 | 13G | 2seventy bio, Inc. TSVT | EcoR1 Capital, LLC | 1,917,063 8.200% | 26,400 (+1.40%) | Filing History |
| 2022-02-14 3:22 pm Sale | 2021-12-31 | 13G | Shattuck Labs, Inc. STTK | EcoR1 Capital, LLC | 0 0.000% | -3,295,088 (Position Closed) | Filing History |
| 2022-02-14 3:21 pm Purchase | 2021-12-31 | 13G | Alector, Inc. ALEC | EcoR1 Capital, LLC | 4,994,970 6.100% | 252,336 (+5.32%) | Filing History |
| 2022-02-14 3:21 pm Purchase | 2021-12-31 | 13G | Ovid Therapeutics Inc. OVID | EcoR1 Capital, LLC | 6,082,200 8.900% | 6,082,200 (New Position) | Filing History |
| 2022-02-14 3:19 pm Purchase | 2021-12-31 | 13G | Solid Biosciences Inc. SLDB | EcoR1 Capital, LLC | 613,513 8.300% | 81,667 (+15.36%) | Filing History |
| 2022-02-14 3:03 pm Purchase | 2021-12-31 | 13G | Avidity Biosciences, Inc. RNA | EcoR1 Capital, LLC | 2,759,505 5.900% | 655,555 (+31.16%) | Filing History |
| 2022-02-14 3:03 pm Sale | 2021-12-31 | 13G | Neoleukin Therapeutics, Inc. NLTX | EcoR1 Capital, LLC | 43,031 2.000% | -113,104 (-72.44%) | Filing History |
| 2022-02-14 3:02 pm Purchase | 2021-12-31 | 13G | ORIC Pharmaceuticals, Inc. ORIC | EcoR1 Capital, LLC | 3,468,944 8.800% | 376,726 (+12.18%) | Filing History |
| 2022-02-14 3:01 pm Purchase | 2021-12-31 | 13G | Morphic Holding, Inc. MORF | EcoR1 Capital, LLC | 3,951,566 10.700% | 1,111,682 (+39.15%) | Filing History |
| 2022-02-14 2:38 pm Unchanged | 2021-12-31 | 13G | Atreca, Inc. BCEL | EcoR1 Capital, LLC | 0 0.000% | 0 (Unchanged) | Filing History |
| 2022-02-14 2:17 pm Sale | 2021-12-31 | 13G | Geron Corporation GERN | EcoR1 Capital, LLC | 9,615,385 2.900% | -18,939,925 (-66.33%) | Filing History |
| 2022-02-14 2:16 pm Sale | 2021-12-31 | 13G | Atreca, Inc. BCEL | EcoR1 Capital, LLC | 0 0.000% | -2,426,685 (Position Closed) | Filing History |